Although Ms. Lynch said Aetna has been providing the DOJ with “a lot of information” in a second review round, she refrained from commenting too heavily on the DOJ’s process. “I know it is a little bit frustrating,” she said in answer to questions at a recent Goldman Sachs healthcare conference in California, according to the report. “I really do want to be respectful of the Department of Justice’s role.”
Ms. Lynch added that Aetna has already won regulatory approval in 15 states, meaning it only needs five more states to move ahead with the merger.
More articles on payer issues:
Ambulatory providers name their most and least favorite payers: 9 survey findings
Connecticut spurns open records request about proposed Anthem-Cigna merger
HHS tightens regulations for short-term health coverage
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
